系统性红斑狼疮与类风湿关节炎中与心血管疾病相关的新基因变异
在系统性红斑狼疮(SLE,n=1045)与类风湿关节炎(RA,n=824)患者中比较自身免疫风险位点单核苷酸多态性与心血管疾病(CVD)表现的关联,并在第二SLE队列(n=1043)中复制。IL19风险等位基因rs17581834(T)与SLE及RA的卒中/心肌梗死相关(meta分析OR 2.5(2.0至2.9),P=3.5×10-7),在一般人群对照中无此关联;SRP54-AS1风险等位基因rs799454(G)仅与SLE的卒中/短暂性脑缺血发作相关。
要点
- IL19风险等位基因rs17581834(T)与SLE和RA的卒中/心肌梗死风险升高相关,在一般人群中无关联。
- SRP54-AS1风险等位基因rs799454(G)与SLE的卒中/短暂性脑缺血发作相关,与RA无关。
- 携带IL19风险等位基因的SLE患者血浆IL10水平(P=0.004)和抗磷脂抗体(P=0.01)升高。
核心结论
- IL19风险等位基因与SLE和RA的卒中/心肌梗死相关,但在一般人群中无关联,提示炎症性风湿病中CVD发病机制可能涉及共同的免疫通路。
研究设计与样本
- 对SLE患者(n=1045)使用200K Immunochip SNP芯片(Illumina)进行基因分型,比较有无不同CVD表现患者间的等位基因频率。
- 结果在第二SLE队列(n=1043)和RA队列(n=824)中复制,并分析一般人群公开遗传数据、进行电泳迁移率变动分析、测定细胞因子水平及抗磷脂抗体(aPLs)出现情况。
主要发现
- 在两个SLE人群中识别出两个新的疑似风险位点与CVD风险升高相关,校正传统CVD危险因素后仍存在关联。
- IL19风险等位基因rs17581834(T)与SLE的卒中/心肌梗死相关(OR 2.3(1.5至3.4),P=8.5×10-5),与RA的卒中/心肌梗死相关(OR 2.8(1.4至5.6),P=3.8×10-3),meta分析OR 2.5(2.0至2.9),P=3.5×10-7,但在一般人群对照中无关联。
- IL19风险等位基因影响蛋白结合,携带该风险等位基因的SLE患者血浆IL10水平升高(P=0.004)、aPL升高(P=0.01)。
- SRP54-AS1风险等位基因rs799454(G)与SLE的卒中/短暂性脑缺血发作相关(OR 1.7(1.3至2.2),P=2.5×10-5),与RA无关联。
- SRP54-AS1风险等位基因是四个基因的表达数量性状位点。
关键数值与推荐
- IL19风险等位基因rs17581834(T)与SLE卒中/心肌梗死:OR 2.3(1.5至3.4),P=8.5×10-5。
- IL19风险等位基因rs17581834(T)与RA卒中/心肌梗死:OR 2.8(1.4至5.6),P=3.8×10-3。
- IL19风险等位基因rs17581834(T)与卒中/心肌梗死meta分析:OR 2.5(2.0至2.9),P=3.5×10-7。
- SRP54-AS1风险等位基因rs799454(G)与SLE卒中/短暂性脑缺血发作:OR 1.7(1.3至2.2),P=2.5×10-5。
- 携带IL19风险等位基因的SLE患者血浆IL10升高P=0.004,aPL升高P=0.01。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) have increased risk of cardiovascular disease (CVD). We investigated whether single nucleotide polymorphisms (SNPs) at autoimmunity risk loci were associated with CVD in SLE and RA. METHODS: Patients with SLE (n=1045) were genotyped using the 200K Immunochip SNP array (Illumina). The allele frequency was compared between patients with and without different manifestations of CVD. Results were replicated in a second SLE cohort (n=1043) and in an RA cohort (n=824). We analysed publicly available genetic data from general population, performed electrophoretic mobility shift assays and measured cytokine levels and occurrence of antiphospholipid antibodies (aPLs). RESULTS: We identified two new putative risk loci associated with increased risk for CVD in two SLE populations, which remained after adjustment for traditional CVD risk factors. An IL19 risk allele, rs17581834(T) was associated with stroke/myocardial infarction (MI) in SLE (OR 2.3 (1.5 to 3.4), P=8.5×10-5) and RA (OR 2.8 (1.4 to 5.6), P=3.8×10-3), meta-analysis (OR 2.5 (2.0 to 2.9), P=3.5×10-7), but not in population controls. The IL19 risk allele affected protein binding, and SLE patients with the risk allele had increased levels of plasma-IL10 (P=0.004) and aPL (P=0.01). An SRP54-AS1 risk allele, rs799454(G) was associated with stroke/transient ischaemic attack in SLE (OR 1.7 (1.3 to 2.2), P=2.5×10-5) but not in RA. The SRP54-AS1 risk allele is an expression quantitative trait locus for four genes. CONCLUSIONS: The IL19 risk allele was associated with stroke/MI in SLE and RA, but not in the general population, indicating that shared immune pathways may be involved in the CVD pathogenesis in inflammatory rheumatic diseases.
引用
- Leonard D, Svenungsson E, Dahlqvist J, et al. Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis. 2018. PMID: 29514802. doi:10.1136/annrheumdis-2017-212614
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。